Bullous Lesions at Polyethylene Glycol Interferon-Alpha-2a Inoculation Site in a Hepatitis C Virus-Infected Subject

    January 2007 in “ Acta Dermato Venereologica
    MA Montesu, V Siddi, Rosanna Satta, C Pirodda, Francesca Cottoni
    Image of study
    TLDR A patient developed a blister at the injection site after hepatitis C treatment.
    A patient with chronic hepatitis C virus (HCV) infection developed a bullous lesion at the inoculation site after treatment with polyethylene glycol interferon-alpha-2a (PEG-IFN-α-2a). This case added to the known dermatological side effects of PEG-IFN, which included both widespread issues like hair loss, pruritus, and vitiligo, and localized issues such as cutaneous ulcerations and necrosis.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Don’t Get Too Hyped About PP405. We've Seen This Movie Before.

      in Research/Science  205 upvotes 1 week ago
      PP405 is a new hair loss treatment showing early promise with a 20% hair density increase, but skepticism exists due to past failures of similar treatments like Pyrilutamide, RU58841, and Bimatoprost. Users debate its potential effectiveness, with some hopeful due to Google's involvement, while others urge caution without more evidence.
      If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

      in Research  830 upvotes 10 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community Topical finasteride now the safest possible path?

      in Finasteride/Dutasteride  84 upvotes 11 months ago
      Topical finasteride is considered a safer option for hair regrowth with fewer systemic side effects compared to oral finasteride. Some users report similar efficacy and side effects between topical and oral treatments, while others prefer topical due to reduced systemic exposure.

      community Kintor Phase 2 Results released KX-826 (pyrilutamide)

      in Research/Science  447 upvotes 2 years ago
      Kintor Pharmaceutical's Phase 2 results with the drug Pyrilutamide, a potential alternative to 5-ARI drugs like Finasteride and Dutasteride but without the side effects. It could be used in combination with other topical treatments such as Minoxidil. The safety of the drug has been demonstrated in 6 months of use, however there are still questions about long term efficacy and systemic absorption.

      community Hair loss journey from 01 24 to 06 25 / HT and 5ARI only

      in Progress Pictures  122 upvotes 1 week ago
      A 28-year-old male shares his hair loss journey, starting with a hair transplant in February 2024 and using finasteride, later switching to dutasteride in January 2025. He has not used minoxidil and is satisfied with the results, despite some side effects like temporary nipple pain and a spike in libido.

    Similar Research

    5 / 1000+ results
      Cutaneous Reactions to Chemotherapeutic Agents

      research Cutaneous Reactions to Chemotherapeutic Agents

      53 citations, May 2001 in “˜The œAmerican journal of the medical sciences”
      Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.
      Index

      research Index

      November 2019 in “Harper's Textbook of Pediatric Dermatology”
      The document is a detailed medical reference on skin and genetic disorders.